Home  >  Products  >  ILKAP (integrin-linked kinase-associated serine/threonine phosphatase ) Blocking Peptide (the C terminal of ILKAP)(100ug)
ILKAP (integrin-linked kinase-associated serine/threonine phosphatase ) Blocking Peptide (the C terminal of ILKAP)(100ug)

ILKAP (integrin-linked kinase-associated serine/threonine phosphatase ) Blocking Peptide (the C terminal of ILKAP)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ILKAP Antibody (ARP62282_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP62282
Size: 100ug
Weight: 43kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: The protein encoded by this gene is a protein serine/threonine phosphatase of the PP2C family. This protein can interact with integrin-linked kinase (ILK/ILK1), a regulator of integrin mediated signaling, and regulate the kinase activity of ILK. Through the interaction with ILK, this protein may selectively affect the signaling process of ILK-mediated glycogen synthase kinase 3 beta (GSK3beta), and thus participate in Wnt signaling pathway.
Alternative names: DKFZp434J2031; FLJ10181; MGC4846; PP2C-DELTA
See Full Product Listings >